 SAN DIEGO, May 28, 2021 PRNewswire -- Halozyme Therapeutics, Inc. NASDAQ: HALO today announced that it will participate at the following investor conferences: The Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 at 11:20 a.m. ET 8:20 a.m. 